Gierga K, Schelhaas H J, Brunt E R, Seidel K, Scherzed W, Egensperger R, de Vos R A I, den Dunnen W, Ippel P F, Petrasch-Parwez E, Deller T, Schöls L, Rüb U
Institute of Clinical Neuroanatomy, J. W. Goethe University, Frankfurt/Main, Germany.
Neuropathol Appl Neurobiol. 2009 Oct;35(5):515-27. doi: 10.1111/j.1365-2990.2009.01015.x. Epub 2009 Jan 30.
Spinocerebellar ataxia type 6 (SCA6) is a late onset autosomal dominantly inherited ataxic disorder, which belongs to the group of CAG repeat, or polyglutamine, diseases. Although, it has long been regarded as a 'pure' cerebellar disease, recent clinical studies have demonstrated disease signs challenging the view that neurodegeneration in SCA6 is confined to the well-known lesions in the cerebellum and inferior olive.
We performed a systematic pathoanatomical study throughout the brains of three clinically diagnosed and genetically confirmed SCA6 patients.
This study confirmed that brain damage in SCA6 goes beyond the known brain predilection sites. In all of the SCA6 patients studied loss of cerebellar Purkinje cells and absence of morphologically intact layer V giant Betz pyramidal cells in the primary motor cortex, as well as widespread degeneration of brainstem nuclei was present. Additional damage to the deep cerebellar nuclei was observed in two of three SCA6 patients.
In view of the known functional role of affected central nervous grey components it is likely that their degeneration at least in part is responsible for the occurrence of a variety of SCA6 disease symptoms.
6型脊髓小脑共济失调(SCA6)是一种迟发性常染色体显性遗传性共济失调疾病,属于CAG重复序列疾病或多聚谷氨酰胺疾病。尽管长期以来它一直被视为一种“纯粹”的小脑疾病,但最近的临床研究表明,疾病症状对SCA6神经退行性变局限于小脑和下橄榄核中已知病变的观点提出了挑战。
我们对3例临床诊断且基因确诊的SCA6患者的全脑进行了系统的病理解剖学研究。
本研究证实,SCA6患者的脑损伤超出了已知的脑偏好部位。在所有研究的SCA6患者中,均出现小脑浦肯野细胞丢失、初级运动皮层中形态完整的V层巨大贝茨锥体细胞缺失以及脑干核广泛变性。在3例SCA6患者中的2例中观察到小脑深部核团的额外损伤。
鉴于受影响的中枢神经灰质成分的已知功能作用,它们的变性很可能至少部分导致了各种SCA6疾病症状的出现。